Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Zenotech Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 532039 | NSE: Not Listed

Watchlist

NSE BSE

70.10

20-Dec-2024

Open
High
Low
Previous Close

73.00
73.00
69.00
71.09

Volume
Traded Value (lacs)
52 Week High
52 Week Low

9288
6.50
107.79
52.23

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

427.82
64.25
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

405.90
N/A
4.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

25.90
9.43
3.74

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
13.91
-0.29

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-5.09
-27.94

P:E (Median)

8 Years
5 Years
3 Years

15.21
29.44
35.65

P:BV (Average)

8 Years
5 Years
3 Years

4.62
4.62
4.79

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.62
23.78
20.18

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 9.76 11.53 -15.35% 9.91 9.26 7.02% 9.11 10.97 -16.96% 10.94 8.80 24.32%
Expenses 7.36 6.02 22.26% 6.48 5.59 15.92% 6.33 5.94 6.57% 5.68 5.22 8.81%
EBITDA 2.40 5.51 -56.44% 3.44 3.67 -6.27% 2.78 5.04 -44.84% 5.26 3.57 47.34%
EBIDTM 24.63% 47.81% 34.66% 39.61% 30.52% 45.88% 48.11% 40.63%
Other Income 0.34 0.19 78.95% 0.34 0.20 70.00% 0.33 0.23 43.48% 0.28 0.16 75.00%
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 1.75 1.81 -3.31% 1.73 1.80 -3.89% 1.73 1.78 -2.81% 1.74 1.81 -3.87%
PBT 2.35 3.90 -39.74% 2.05 2.07 -0.97% 1.37 3.48 -60.63% 3.80 1.93 96.89%
Tax 1.00 1.06 -5.66% 0.76 0.62 22.58% 0.71 -0.19 - 0.44 0.55 -20.00%
PAT 1.35 2.83 -52.30% 1.29 1.44 -10.42% 0.66 3.67 -82.02% 3.36 1.38 143.48%
PATM 13.81% 24.57% 13.01% 15.60% 7.25% 33.42% 30.72% 15.71%
EPS 0.22 0.46 -52.17% 0.21 0.24 -12.50% 0.11 0.60 -81.67% 0.55 0.23 139.13%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 39.72 40.83 42.42 36.57 22.45 26.02 13.03 11.14 2.25 2.06 4.08 Net Sales Growth -2.07% -3.75% 16.00% 62.90% -13.72% 99.69% 16.97% 395.11% 9.22% -49.51% Cost Of Goods Sold 0.20 0.00 0.06 0.00 0.03 0.50 0.72 0.80 1.66 1.90 3.20 Gross Profit 39.52 40.83 42.36 36.56 22.41 25.52 12.31 10.35 0.59 0.15 0.88 GP Margin 99.49% 100% 99.86% 99.97% 99.82% 98.08% 94.47% 92.91% 26.22% 7.28% 21.57% Total Expenditure 25.85 23.61 21.72 19.10 16.07 17.04 16.55 19.01 12.66 10.08 24.13 Power & Fuel Cost - 2.69 3.79 3.25 3.12 3.29 3.68 4.24 1.94 0.98 1.42 % Of Sales - 6.59% 8.93% 8.89% 13.90% 12.64% 28.24% 38.06% 86.22% 47.57% 34.80% Employee Cost - 9.46 7.88 7.10 6.49 5.76 4.98 5.07 3.02 2.25 3.27 % Of Sales - 23.17% 18.58% 19.41% 28.91% 22.14% 38.22% 45.51% 134.22% 109.22% 80.15% Manufacturing Exp. - 8.66 7.63 6.59 4.55 5.61 4.64 5.18 3.00 0.81 1.01 % Of Sales - 21.21% 17.99% 18.02% 20.27% 21.56% 35.61% 46.50% 133.33% 39.32% 24.75% General & Admin Exp. - 2.35 2.02 1.95 1.34 1.72 2.18 3.52 2.90 3.68 14.97 % Of Sales - 5.76% 4.76% 5.33% 5.97% 6.61% 16.73% 31.60% 128.89% 178.64% 366.91% Selling & Distn. Exp. - 0.02 0.02 0.02 0.02 0.03 0.03 0.06 0.04 0.03 0.03 % Of Sales - 0.05% 0.05% 0.05% 0.09% 0.12% 0.23% 0.54% 1.78% 1.46% 0.74% Miscellaneous Exp. - 0.43 0.31 0.19 0.50 0.12 0.32 0.15 0.10 0.41 0.03 % Of Sales - 1.05% 0.73% 0.52% 2.23% 0.46% 2.46% 1.35% 4.44% 19.90% 5.64% EBITDA 13.88 17.22 20.70 17.47 6.38 8.98 -3.52 -7.87 -10.41 -8.02 -20.05 EBITDA Margin 34.94% 42.17% 48.80% 47.77% 28.42% 34.51% -27.01% -70.65% -462.67% -389.32% -491.42% Other Income 1.29 1.00 1.08 0.63 0.41 1.17 4.71 2.37 0.08 0.39 0.35 Interest 0.00 0.00 0.11 1.22 1.55 0.89 0.12 2.45 7.50 7.55 6.65 Depreciation 6.95 7.09 7.17 6.97 6.46 4.85 4.20 3.90 3.87 3.96 4.06 PBT 9.57 11.14 14.50 9.90 -1.22 4.41 -3.13 -11.85 -21.70 -19.14 -30.41 Tax 2.91 2.84 2.92 -12.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 30.41% 25.49% 20.14% -123.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT 6.66 8.30 11.59 22.18 -1.22 10.78 -3.13 -11.85 -19.87 -19.14 -30.41 PAT before Minority Interest 6.66 8.30 11.59 22.18 -1.22 10.78 -3.13 -11.85 -19.87 -19.14 -30.41 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.77% 20.33% 27.32% 60.65% -5.43% 41.43% -24.02% -106.37% -883.11% -929.13% -745.34% PAT Growth -28.54% -28.39% -47.75% - - - - - - - EPS 1.09 1.36 1.90 3.64 -0.20 1.77 -0.51 -1.94 -3.26 -3.14 -4.99

Description TTM Mar 10 Mar 09 Mar 08 Mar 07 Mar 06
Net Sales - 6.57 6.02 8.24 21.83 12.37 Net Sales Growth - 9.14% -26.94% -62.25% 76.48% Cost Of Goods Sold - 2.50 5.10 2.85 5.64 5.77 Gross Profit - 4.07 0.92 5.39 16.19 6.61 GP Margin - 61.95% 15.28% 65.41% 74.16% 53.44% Total Expenditure - 16.01 23.62 18.12 19.09 14.89 Power & Fuel Cost - 1.89 2.11 1.90 0.92 0.14 % Of Sales - 28.77% 35.05% 23.06% 4.21% 1.13% Employee Cost - 4.50 6.98 6.03 5.76 3.69 % Of Sales - 68.49% 115.95% 73.18% 26.39% 29.83% Manufacturing Exp. - 2.92 3.39 2.69 0.90 0.39 % Of Sales - 44.44% 56.31% 32.65% 4.12% 3.15% General & Admin Exp. - 2.74 2.86 2.92 3.03 2.01 % Of Sales - 41.70% 47.51% 35.44% 13.88% 16.25% Selling & Distn. Exp. - 0.07 0.22 0.25 1.45 1.52 % Of Sales - 1.07% 3.65% 3.03% 6.64% 12.29% Miscellaneous Exp. - 1.39 2.96 1.48 1.39 1.38 % Of Sales - 21.16% 49.17% 17.96% 6.37% 11.16% EBITDA - -9.44 -17.60 -9.88 2.74 -2.52 EBITDA Margin - -143.68% -292.36% -119.90% 12.55% -20.37% Other Income - 2.11 5.21 2.17 0.31 0.09 Interest - 1.96 2.05 2.80 2.29 0.70 Depreciation - 3.26 3.07 3.03 1.85 0.28 PBT - -12.54 -17.52 -13.55 -1.09 -3.41 Tax - -0.02 0.05 2.35 -2.74 0.19 Tax Rate - 0.16% -0.29% -17.34% 251.38% -5.57% PAT - -12.52 -17.56 -15.89 1.65 -3.60 PAT before Minority Interest - -12.52 -17.56 -15.89 1.65 -3.60 Minority Interest - 0.00 0.00 0.00 0.00 0.00 PAT Margin - -190.56% -291.69% -192.84% 7.56% -29.10% PAT Growth - - - - - EPS - -2.05 -2.88 -2.60 0.27 -0.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 90.54 82.27 70.64 48.41 49.63 38.90 42.02 -65.91 -46.07 -27.25 Share Capital 61.03 61.03 61.03 61.03 61.03 61.03 61.03 34.43 34.43 34.43 Total Reserves 29.51 21.24 9.61 -12.62 -11.40 -22.13 -19.01 -100.33 -80.49 -61.69 Non-Current Liabilities -4.38 -7.36 -4.41 22.49 0.49 0.34 0.28 0.24 0.20 0.24 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 Unsecured Loans 0.00 0.00 6.00 20.66 0.00 0.00 0.00 0.00 0.01 0.03 Long Term Provisions 1.17 1.02 0.89 0.83 0.49 0.34 0.28 0.24 0.19 0.19 Current Liabilities 13.52 16.61 15.58 14.95 35.44 45.35 39.45 116.42 98.78 90.72 Trade Payables 2.81 3.48 2.07 1.92 4.60 4.12 5.41 5.13 4.25 1.95 Other Current Liabilities 4.35 4.86 5.22 4.59 3.68 3.79 17.26 41.72 26.37 21.29 Short Term Borrowings 0.00 0.00 0.00 0.00 18.66 20.24 0.00 51.20 51.20 51.20 Short Term Provisions 6.37 8.27 8.29 8.44 8.50 17.20 16.77 18.36 16.96 16.28 Total Liabilities 99.68 91.52 81.81 85.85 85.56 84.59 81.75 50.75 52.91 63.71 Net Block 65.58 65.38 70.91 74.23 48.73 43.11 44.43 46.83 48.17 52.13 Gross Block 114.05 106.78 105.13 101.48 69.52 59.05 56.17 54.67 52.13 82.61 Accumulated Depreciation 48.47 41.39 34.22 27.25 20.79 15.94 11.74 7.84 3.96 29.35 Non Current Assets 73.52 75.25 74.43 78.50 79.85 65.39 50.32 48.93 50.39 55.23 Capital Work in Progress 1.96 4.98 0.28 2.18 29.08 16.95 2.32 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.75 4.79 3.15 1.98 1.94 5.33 3.56 2.10 2.21 3.10 Other Non Current Assets 0.23 0.10 0.10 0.10 0.10 0.00 0.00 0.00 0.00 0.00 Current Assets 26.16 16.26 7.37 7.35 5.71 19.19 31.42 1.82 2.53 8.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 0.84 0.00 0.06 0.06 0.09 0.58 0.82 0.92 1.59 2.04 Sundry Debtors 3.25 3.32 3.93 3.80 1.86 2.36 0.00 0.00 0.35 0.40 Cash & Bank 19.69 11.14 2.41 2.46 1.12 13.25 29.16 0.68 0.45 5.79 Other Current Assets 2.38 0.97 0.54 0.23 2.64 3.00 1.44 0.21 0.15 0.26 Short Term Loans & Adv. 0.71 0.83 0.43 0.79 2.39 2.50 0.89 0.06 0.01 0.03 Net Current Assets 12.64 -0.34 -8.20 -7.60 -29.73 -26.15 -8.03 -114.60 -96.25 -82.24 Total Assets 99.68 91.51 81.80 85.85 85.56 84.58 81.74 50.75 52.92 63.71

Description Mar 10 Mar 09 Mar 08 Mar 07 Mar 06
Shareholder's Funds 96.48 108.61 126.37 54.16 32.47 Share Capital 34.42 34.42 34.35 28.81 15.68 Total Reserves 62.02 74.19 92.02 25.35 5.66 Non-Current Liabilities 10.13 16.78 18.96 33.21 32.04 Secured Loans 9.76 16.65 18.47 31.80 24.86 Unsecured Loans 0.37 0.13 0.50 3.70 6.57 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 Current Liabilities 3.97 5.43 7.73 9.99 9.46 Trade Payables 2.10 3.81 3.99 7.16 7.61 Other Current Liabilities 1.33 1.22 3.40 2.53 1.76 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 0.54 0.40 0.33 0.30 0.09 Total Liabilities 110.58 130.82 153.06 97.36 73.97 Net Block 70.62 61.94 61.34 60.38 15.61 Gross Block 82.39 70.96 67.26 63.10 16.40 Accumulated Depreciation 11.78 9.02 5.92 2.72 0.79 Non Current Assets 83.34 85.63 76.36 69.87 55.26 Capital Work in Progress 12.73 23.69 15.02 9.48 39.64 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 Current Assets 25.45 42.19 72.50 22.00 13.73 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 2.32 2.90 5.46 5.24 2.35 Sundry Debtors 1.73 0.59 1.90 9.45 4.92 Cash & Bank 16.34 32.64 60.40 2.33 2.40 Other Current Assets 5.06 1.24 1.27 0.03 4.07 Short Term Loans & Adv. 4.76 4.81 3.47 4.95 4.07 Net Current Assets 21.49 36.76 64.77 12.01 4.27 Total Assets 110.56 130.83 153.06 97.37 73.97

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 11.82 20.66 17.67 5.74 11.38 -14.04 -16.25 1.64 -4.80 -7.72 PBT 11.14 14.50 9.90 -1.22 10.78 -3.13 -11.85 -19.87 -19.14 -30.41 Adjustment 6.17 6.86 8.01 7.66 -1.68 -0.07 4.63 9.55 11.66 10.64 Changes in Working Capital -4.41 0.49 0.76 -0.59 2.56 -10.38 -8.75 11.86 1.65 12.07 Cash after chg. in Working capital 12.90 21.85 18.67 5.86 11.66 -13.58 -15.97 1.53 -5.82 -7.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.07 -1.19 -1.00 -0.12 -0.28 -0.46 -0.28 0.10 1.03 -0.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -21.15 -5.82 -1.84 -4.82 -20.79 -16.19 -2.65 -0.69 5.50 0.34 Net Fixed Assets -4.25 -6.35 -1.75 -5.06 -22.60 -17.51 -3.82 -2.54 30.48 0.02 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -16.90 0.53 -0.09 0.24 1.81 1.32 1.17 1.85 -24.98 0.32 Cash from Financing Activity 0.00 -6.11 -15.87 0.45 -2.70 15.02 46.83 -0.72 -0.83 6.77 Net Cash Inflow / Outflow -9.33 8.73 -0.04 1.38 -12.11 -15.21 27.92 0.23 -0.13 -0.60 Opening Cash & Equivalents 11.14 2.41 2.46 1.08 13.20 28.40 0.48 0.25 0.38 6.40 Closing Cash & Equivalent 1.82 11.14 2.41 2.46 1.08 13.20 28.40 0.48 0.25 5.79

Description Mar 10 Mar 09 Mar 08 Mar 07 Mar 06
Cash From Operating Activity -9.85 -15.55 -2.98 -6.98 -15.78 PBT -12.54 -17.52 -13.55 -1.09 -3.41 Adjustment 4.17 2.35 4.92 4.79 -4.35 Changes in Working Capital -1.55 1.43 6.25 -9.11 -1.88 Cash after chg. in Working capital -9.92 -13.74 -2.38 -5.41 -9.64 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.28 -1.09 -0.75 -0.15 -0.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 29.11 20.18 -67.30 -15.29 -56.05 Net Fixed Assets -1.13 -12.78 -9.67 -16.52 Net Investments 0.00 1.20 0.00 0.00 Others 30.24 31.76 -57.63 1.23 Cash from Financing Activity -8.34 -3.81 70.05 22.20 74.23 Net Cash Inflow / Outflow 10.91 0.82 -0.23 -0.07 2.40 Opening Cash & Equivalents 1.42 0.60 0.83 2.40 0.00 Closing Cash & Equivalent 12.34 1.42 0.60 2.33 2.40

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 14.84 13.48 11.57 7.93 8.13 6.37 6.88 -18.17 -12.70 -7.51 ROA 8.68% 13.37% 26.45% -1.42% 12.67% -3.76% -17.89% -38.33% -32.82% -45.43% ROE 9.60% 15.15% 37.26% -2.48% 24.35% -7.73% 0.00% 0.00% 0.00% 0.00% ROCE 12.89% 18.39% 15.26% 0.48% 18.32% -5.95% -61.88% 0.00% -65.68% -61.52% Fixed Asset Turnover 0.37 0.40 0.35 0.26 0.40 0.23 0.20 0.04 0.03 0.05 Receivable days 29.38 31.20 38.59 46.02 29.56 33.08 0.08 28.21 61.96 19.78 Inventory Days 7.51 0.00 0.61 1.27 4.76 19.68 28.57 203.13 302.43 239.52 Payable days 0.00 0.00 0.00 0.00 3153.54 94.45 98.95 125.78 112.50 73.48 Cash Conversion Cycle 36.89 31.20 39.20 47.29 -3119.22 -41.68 -70.30 105.55 251.89 185.82 Total Debt/Equity 0.00 0.00 0.08 0.43 0.38 0.52 0.00 -0.82 -1.18 -1.99 Interest Cover 0.00 130.25 9.15 0.21 13.08 -25.57 -3.84 -1.65 -1.54 -3.57

Description Mar 10 Mar 09 Mar 08 Mar 07 Mar 06
Book Value (Rs.) 26.10 29.12 33.76 16.03 9.90 ROA -10.38% -12.37% -12.69% 1.92% -4.87% ROE -12.51% -15.42% -18.61% 5.07% -22.00% ROCE -9.32% -11.74% -9.54% 1.68% -4.60% Fixed Asset Turnover 0.09 0.09 0.13 0.56 0.80 Receivable days 61.38 69.41 241.73 116.82 136.09 Inventory Days 137.65 232.92 227.91 61.65 64.93 Payable days 69.38 76.16 111.09 146.73 212.90 Cash Conversion Cycle 129.65 226.18 358.55 31.74 -11.88 Total Debt/Equity 0.11 0.16 0.16 0.73 1.92 Interest Cover -5.41 -7.53 -3.84 0.52 -3.89

Top Investors:

padmasree chigurupati

pat financial consultants private limited

dr. jayaram chigurupati

minal bharat patel

Annual Reports:

News Update:

Zenotech Laboratorie - Quarterly Results
23rd Oct 2024, 15:03 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback